Page last updated: 2024-09-04

rupatadine and Electrocardiogram QT Prolonged

rupatadine has been researched along with Electrocardiogram QT Prolonged in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferber, G; Fernandes, S; Izquierdo, I; Santamaría, E; Täubel, J1
Fité-Mora, R1

Trials

1 trial(s) available for rupatadine and Electrocardiogram QT Prolonged

ArticleYear
Cardiac Safety of Rupatadine in a Single-Ascending-Dose and Multiple-Ascending-Dose Study in Healthy Japanese Subjects, Using Intensive Electrocardiogram Assessments-Comparison With the Previous White Caucasian Thorough QT Study.
    Clinical pharmacology in drug development, 2018, Volume: 7, Issue:1

    Topics: Asian People; Cyproheptadine; Double-Blind Method; Electrocardiography; Food-Drug Interactions; Healthy Volunteers; Heart Rate; Humans; Long QT Syndrome; White People

2018

Other Studies

1 other study(ies) available for rupatadine and Electrocardiogram QT Prolonged

ArticleYear
Torsade de pointes associated with rupatadine.
    Revista espanola de cardiologia, 2009, Volume: 62, Issue:3

    Topics: Cyproheptadine; Histamine H1 Antagonists; Humans; Long QT Syndrome; Platelet Activating Factor; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Spain; Torsades de Pointes

2009